Acutaas Chemicals Limited

rs,

hemistry’s apex May 16, 2026 To, The Listing Department, BSE LIMITED, Phiroze Jeejeebhoy Towers, Dalal Street, Fort Mumbai- 400 001 To, The Listing Department National Stock Exchange of India

87.7%

0+ Products ~600 Customers ~55 Countries served since inception Pharmaceutical Intermediates 87.7% 50-90% Global Market Share in Key Intermediates Capabilities to Manufacture up to N-1 Stages wi

90%

ts ~600 Customers ~55 Countries served since inception Pharmaceutical Intermediates 87.7% 50-90% Global Market Share in Key Intermediates Capabilities to Manufacture up to N-1 Stages with diffe

1.2%

different ROS 90%+ Products are backward integrated to Basic Chemicals Semiconductor Chemicals 1.2% Only Manufacturer In India for photoresist chemicals Parts Per Billion Purity Expansion Into

rs 10

ery Chemicals No Commercial Revenue 1st Electrolyte Additives Manufacturer In India 5+ Customers 10+ Products in Pipeline 5 Manufacturing Facilities (South Korean Manufacturing capex is ongoing) C

11.2%

turing capex is ongoing) Commodity Chemicals Corporate Presentation | Data as of 31st March 2026 11.2% 3 30+ Products Serving Various Industries Replacing Old Products with new products From Drea

₹1,000 Million

ellence in HSE Management System creation and implementation 2015 Crossed turnover milestone of ₹1,000 Million 2020 Received the second US FDA EIR for the Sachin manufacturing unit Commissioned a new R&D la

₹1,500 Million

d’ for Outstanding Export Performance—Panel-II: Inorganic, Organic, and Agro Chemicals Achieved ₹1,500 Million turnover Expanded infrastructure with 1,050 MT raw material storage and enhanced warehousing 20

1,050 MT

anic, Organic, and Agro Chemicals Achieved ₹1,500 Million turnover Expanded infrastructure with 1,050 MT raw material storage and enhanced warehousing 2021 Acquired Ankleshwar and Jhagadia units from G

₹5,000 Million

from Gujarat Organics Ltd. Launched successful IPO; shares listed on BSE and NSE 2022 Achieved ₹5,000 Million in sales Chairman and MD Mr. Naresh Patel named Outstanding Business Leader of the Year by FGI

₹10,000 Million

ng Plant Pharma 586 KL Specialty 514 KL 1,100 KL 1 R&D Centre 900+ Employees 2025 Surpassed ₹10,000 Million in sales Rebranded as Acutaas Chemicals Ltd. to reflect a sharper focus on specialty and custom

₹ 11,741

ing Corporate Presentation | Data as of 31st March 2026 4 Advanced Pharmaceutical Intermediates ₹ 11,741 Mn Revenue FY26 160+ Customer Served 25+ Countries (Customer Location) 2 Manufacturing Facilitie

“Invested Plant (Ongoing) • Total capacity of around 16 • Expanding pilot plant capacity MW installed to support higher projects churnout from R&D • Pilot will also have capacity for HP API chemicals • Capex Status: Under Construction • Majority of company’s present electricity requirements across its key facilities will be met through renewable energy sources • Capex Status: Completed”

Manufacturer

1

Niche Industry

1

Knowledge

1

Capex Pipeline

1

For more information please contact

1

Niche Industry

Commercially selling products with PPB purity Niche Industry with high entry barriers Driven by Deep Industry

Knowledge

Partners with more than 30+ years of experience in Semiconductor Industry giving us edge Corporate Presentation | Data as of 31st March 2026 6 Grow Indichem venture with advanced chemicals to get better relationship with customers in South Korea and nearby countries Specialty Chemicals: Energy Storage System (Battery Chemicals) No Commercial Revenue FY26 Battery Chemicals Our Strategy Expand existing products with new customers 5+ Customer (have validated our products) 3 Countries (Customer Location) 1 Manufacturing Facility (Part of Jhagadia Unit) What makes us different Commercialized Products 10+ Products In Pipeline Vinylene Carbonate Fluoroethylene Carbonate 2 products Closer to commercia lization More products at different stages of sampling Calibrated capex to manage demand for the products while maintaining the healthy Balance Sheet Introduce new products and widen the product basket Pioneering Battery Chemcials in India Indigenously Engineered 1st Electrolyte Additives Manufac

Capex Pipeline

New R&D Centre | Land Acquisition for Future Growth Corporate Presentation | Data as of 31st March 2026 10 Supported by able R&D team 130+ Team Size 30+ PHDs 26 Process Patents (8 patents published; 10 patents granted, and 8 patents under publication) 43+ Reaction Capabilities Data Integrity Electronic Lab Notebook CAPABILITY • 43+ Reaction Capabilities supporting various industries: Pharmaceutical, Semiconductor, Battery Chemicals, Polymers and Monomers, Agrochemicals, Cosmetics, etc. TECHNOLOGY • Continuous Flow Reaction • Photochemistry • Advanced Batch Manufacturing • Batch Manufacturing Corporate Presentation | Data as of 31st March 2026 11 ANALYTICAL SUPPORT • Genotoxic impurity evaluation • Nitrosamine impurity evaluation • Analytical method development and validation • Full fledge documentation support EQUIPMENT • LCMASS • GCMASS • NMR • ICPMS • ICPOS • IC • IR • DSC • UV spectrophotometer Our People The Driving Force of Our Young Startup 1,000+ Employees ~15% Employee Turnover

For more information please contact

Acutaas Chemicals Limited Rahul Thakur Senior Manager – Investor Relations rahul.thakur@acutaas.com www.acutaas.com www.acutaas.com www.acutaas.com